Looking for a different product? Our Business Development team can help.
Contact Us| Select | ATC Classification | Product | Form | Dosage Strengths | Dossier Availability | Stability Coverage | CPP Availability |
|---|---|---|---|---|---|---|---|
| A - ALIMENTARY TRACT AND METABOLISM | Colecalciferol | Capsule, Soft Gel | 5,600IU | Available | Available | ||
| A - ALIMENTARY TRACT AND METABOLISM | Colecalciferol | Capsule, Soft Gel | 20,000IU | Available | Available | ||
| A - ALIMENTARY TRACT AND METABOLISM | Colecalciferol | Capsule, Soft Gel | 25,000IU | Available | Available | ||
| A - ALIMENTARY TRACT AND METABOLISM | Colecalciferol | Capsule, Soft Gel | 50,000IU | Available | Available | ||
| A - ALIMENTARY TRACT AND METABOLISM | Dapagliflozin | Film-Coated Tablet | 5mg, 10mg | Available | Zone IVb | Available | |
| A - ALIMENTARY TRACT AND METABOLISM | Dapagliflozin/Metformin | Film-Coated Tablet | 5mg/850mg, 5mg/1000mg | Available | Q2 2027 | ||
| A - ALIMENTARY TRACT AND METABOLISM | Empagliflozin | Film-Coated Tablet | 10mg, 25mg | Available | Zone IVb | Q2 2028 | |
| A - ALIMENTARY TRACT AND METABOLISM | Esomeprazole | Capsule, Gastro Resistant | 20mg, 40mg | Q4 2026 | Q3 2028 | ||
| A - ALIMENTARY TRACT AND METABOLISM | Esomeprazole | Tablet, Gastro Resistant | 20mg, 40mg | Available | Available | ||
| A - ALIMENTARY TRACT AND METABOLISM | Gliclazide | Tablet, Modified Release | 30mg, 60mg | Available | Zone IVb | Available | |
| A - ALIMENTARY TRACT AND METABOLISM | Lansoprazole | Capsule, Gastro Resistant | 15mg, 30mg | Available | Available | ||
| A - ALIMENTARY TRACT AND METABOLISM | Linagliptin | Film-Coated Tablet | 5mg | Available | Zone IVb | Available | |
| A - ALIMENTARY TRACT AND METABOLISM | Metformin | Tablet | 500mg, 850mg, 1000mg | Available | Available | ||
| A - ALIMENTARY TRACT AND METABOLISM | Migalastat | Capsule, Hard | 123mg | Available | Q1 2028 | ||
| A - ALIMENTARY TRACT AND METABOLISM | Omeprazole | Capsule, Gastro Resistant | 10mg, 20mg, 40mg | Q4 2028 | Q3 2030 | ||
| A - ALIMENTARY TRACT AND METABOLISM | Sapropterin | Soluble Tablet | 100mg | Available | Available | ||
| A - ALIMENTARY TRACT AND METABOLISM | Sitagliptin | Film-Coated Tablet | 25mg, 50mg, 100mg | Available | Zone IVb | Available | |
| A - ALIMENTARY TRACT AND METABOLISM | Vildagliptin | Tablet | 50mg | Available | Available | ||
| A - ALIMENTARY TRACT AND METABOLISM | Vildagliptin/Metformin | Film-Coated Tablet | 50mg/850mg, 50mg/1000mg | Available | Available | ||
| B - BLOOD AND BLOOD FORMING ORGANS | Apixaban | Film-Coated Tablet | 2.5mg, 5mg | Available | Zone IVb | Available | |
| B - BLOOD AND BLOOD FORMING ORGANS | Edoxaban | Film-Coated Tablet | 15mg, 30mg, 60mg | Available | Zone IVb | Available | |
| B - BLOOD AND BLOOD FORMING ORGANS | Eltrombopag | Film-Coated Tablet | 25mg, 50mg, 75mg | Available | Zone IVb | Available | |
| B - BLOOD AND BLOOD FORMING ORGANS | Ferric Carboxymaltose | SolutionFor Injection/Infusion | 50mg/ml | Available | Available | ||
| B - BLOOD AND BLOOD FORMING ORGANS | Icatibant | Solution for injection (PFS) | 10mg/ml | Available | Available | ||
| B - BLOOD AND BLOOD FORMING ORGANS | Prasugrel | Film-Coated Tablet | 5mg, 10mg | Available | Available | ||
| B - BLOOD AND BLOOD FORMING ORGANS | Rivaroxaban | Film-Coated Tablet | 2.5mg, 10mg, 15mg, 20mg | Available | Zone IVb | Q4 2026 | |
| B - BLOOD AND BLOOD FORMING ORGANS | Ticagrelor | Film-Coated Tablet | 60mg, 90mg | Available | Available | ||
| C - CARDIOVASCULAR | Ambrisentan | Film-Coated Tablet | 5mg, 10mg | Available | Zone IVb | Available | |
| C - CARDIOVASCULAR | Amlodipine Besilate | Film-Coated Tablet | 5mg, 10mg | Available | Zone IVb | Available | |
| C - CARDIOVASCULAR | Amlodipine/Indapamide/Perindopril Arginine | Film-Coated Tablet | 5mg/1.25mg/5mg, 5mg/2.5mg/10mg, 10mg/1.25mg/5mg, 10mg/2.5mg/10mg | Available | Zone IVb | Available | |
| C - CARDIOVASCULAR | Amlodipine/Valsartan/HCT | Film-Coated Tablet | 5mg/160mg/12.5mg, 10mg/320mg/25mg | Available | Available | ||
| C - CARDIOVASCULAR | Atenolol | Tablet | 25mg, 50mg, 100mg | Available | Available | ||
| C - CARDIOVASCULAR | Atorvastatin | Film-Coated Tablet | 10mg, 20mg, 30mg, 40mg, 60mg, 80mg | Available | Zone IVb | Available | |
| C - CARDIOVASCULAR | Barnidipine | Capsule, Extended Release | 10mg, 20mg | Available | Available | ||
| C - CARDIOVASCULAR | Bisoprolol Fumarate | Film-Coated Tablet | 1.25mg, 2.5mg, 3.75mg, 5mg, 7.5mg, 10mg | Q3 2026 | Zone IVb | Q3 2028 | |
| C - CARDIOVASCULAR | Bosentan | Film-Coated Tablet | 62.5mg, 125mg | Available | Available | ||
| C - CARDIOVASCULAR | Candesartan Cilexetil | Tablet | 4mg, 8mg, 16mg, 32mg | Q2 2028 | Zone IVb | Q1 2030 | |
| C - CARDIOVASCULAR | Candesartan Cilexetil/HCT | Tablet | 8/12.5mg, 16/12.5mg, 32/12.5mg, 32/25mg | Q2 2027 | Q1 2029 | ||
| C - CARDIOVASCULAR | Carvedilol | Film-Coated Tablet | 3.125mg, 6.25mg, 12.5mg, 25mg | Q1 2028 | Zone IVb | Q4 2029 | |
| C - CARDIOVASCULAR | Doxazosin | Tablet | 1mg, 2mg, 4mg | Q1 2028 | Q1 2030 | ||
| C - CARDIOVASCULAR | Furosemide | Tablet | 125mg, 250mg, 500mg | Available | Available | ||
| C - CARDIOVASCULAR | Hydrochlorothiazide | Tablet | 12.5mg, 25mg, 50mg | Available | Q3 2027 | ||
| C - CARDIOVASCULAR | Irbesartan | Film-Coated Tablet | 75mg, 150mg, 300mg | Available | Zone IVb | Available | |
| C - CARDIOVASCULAR | Irbesartan/HCT | Film-Coated Tablet | 150mg/12.5mg, 300mg/12.5mg, 300mg/25mg | Available | Zone IVb | Available | |
| C - CARDIOVASCULAR | Ivabradine | Film-Coated Tablet | 5mg, 7.5mg | Available | Zone IVb | Available | |
| C - CARDIOVASCULAR | Lisinopril | Film-Coated Tablet | 2.5mg, 5mg, 10mg, 20mg, 30mg, 40mg | Q3 2027 | Q2 2029 | ||
| C - CARDIOVASCULAR | Losartan | Film-Coated Tablet | 12.5mg, 25mg, 50mg, 100mg | Q3 2026 | Zone IVb | Q3 2028 | |
| C - CARDIOVASCULAR | Losartan/HCT | Film-Coated Tablet | 50mg/12.5mg, 100mg/12.5mg, 100mg/25mg | Q2 2027 | Q4 2028 | ||
| C - CARDIOVASCULAR | Macitentan | Film-Coated Tablet | 10mg | Available | Available | ||
| C - CARDIOVASCULAR | Midodrine | Tablet | 2.5mg, 5mg | Available | Available | ||
| C - CARDIOVASCULAR | Nebivolol | Tablet | 5mg | Available | Zone IVb | Available | |
| C - CARDIOVASCULAR | Nebivolol/HCT | Film-Coated Tablet | 5mg/12.5mg, 5mg/25mg | Available | Zone IVb | Available | |
| C - CARDIOVASCULAR | Olmesartan | Film-Coated Tablet | 5mg, 10mg, 20mg, 40mg | Available | Zone IVb | Available | |
| C - CARDIOVASCULAR | Olmesartan/Amlodipine Besilate | Film-Coated Tablet | 5mg/20mg, 5mg/40mg, 10mg/40mg | Available | Available | ||
| C - CARDIOVASCULAR | Olmesartan/Amlodipine Besilate/HCT | Film-Coated Tablet | 5mg/20mg/12.5mg, 5mg/40mg/12.5mg, 5mg/40mg/25mg, 10mg/40mg/12.5mg, 10mg/40mg/25mg | Available | Available | ||
| C - CARDIOVASCULAR | Olmesartan/HCT | Film-Coated Tablet | 20mg/12.5mg, 20mg/25mg, 40mg/12.5mg, 40mg/25mg | Available | Zone IVb | Available | |
| C - CARDIOVASCULAR | Perindopril Erbumine/Amlodipine | Tablet | 4mg/5mg, 4mg/10mg, 8mg/5mg, 8mg/10mg | Available | Zone IVb | ||
| C - CARDIOVASCULAR | Perindopril Tosilate | Film-Coated Tablet | 2.5mg, 5mg, 10mg | Available | Zone IVb | Available | |
| C - CARDIOVASCULAR | Perindopril Tosilate/Amlodipine | Tablet | 5mg/5mg, 5mg/10mg, 10mg/5mg, 10mg/10mg | Available | Zone IVb | ||
| C - CARDIOVASCULAR | Ranolazine | Tablet, Prolonged Release | 375mg, 500mg, 750mg | Available | Available | ||
| C - CARDIOVASCULAR | Riociguat | Film-Coated Tablet | 0.5mg, 1mg, 1.5mg, 2mg, 2.5mg | Available | Q3 2027 | ||
| C - CARDIOVASCULAR | Rosuvastatin | Film-Coated Tablet | 5mg, 10mg, 20mg, 40mg | Available | Available | ||
| C - CARDIOVASCULAR | Rosuvastatin | Film-Coated Tablet | 15mg, 30mg | Available | Available | ||
| C - CARDIOVASCULAR | Simvastatin | Film-Coated Tablet | 5mg, 10mg, 20mg, 40mg, 80mg | Q4 2027 | Q1 2030 | ||
| C - CARDIOVASCULAR | Spironolactone | Film-Coated Tablet | 25mg, 50mg, 100mg | Q4 2028 | Q3 2030 | ||
| G - GENITO-URINARY SYSTEM AND SEX HORMONES | Desfesoterodine | Tablet, Prolonged Release | 3.5mg, 7mg | Available | Available | ||
| G - GENITO-URINARY SYSTEM AND SEX HORMONES | Vardenafil | Film-Coated Tablet | 5mg, 10mg, 20mg | Available | Zone IVb | Available | |
| J - ANTIINFECTIVES FOR SYSTEMIC USE | Abacavir Sulfate/Dolutegravir Sodium/Lamivudine | Film-Coated Tablet | 600mg/50mg/300mg | Q4 2027 | Q4 2029 | ||
| J - ANTIINFECTIVES FOR SYSTEMIC USE | Dolutegravir Sodium/Lamivudine | Film-Coated Tablet | 50mg/300mg | Q4 2026 | Q2 2029 | ||
| J - ANTIINFECTIVES FOR SYSTEMIC USE | Emtricitabine/Rilpivirine/Tenofovir Alafenamide | Film-Coated Tablet | 200mg/25mg/25mg | Available | Q1 2027 | ||
| J - ANTIINFECTIVES FOR SYSTEMIC USE | Micafungin | Powder For Concentrate For Solution For Infusion | 50mg, 100mg | Available | Cold Chain | Available | |
| J - ANTIINFECTIVES FOR SYSTEMIC USE | Moxifloxacin | Film-Coated Tablet | 400mg | Available | Available | ||
| J - ANTIINFECTIVES FOR SYSTEMIC USE | Valganciclovir | Film-Coated Tablet | 450mg | Available | Zone IVb | Available | |
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Abemaciclib | Film-Coated Tablet | 50mg, 100mg, 150mg, 200mg (200mg for International Markets Only At Present) | Q3 2028 | Zone IVb | Available | |
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Alectinib | Capsule, Hard | 150mg | Q4 2028 | Zone IVb | Q3 2030 | |
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Apalutamide | Film-Coated Tablet | 60mg, 240mg | Q1 2028 | Zone IVb | Q4 2029 | |
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Apremilast | Film-Coated Tablet | 10mg, 20mg, 30mg | Available | Zone IVb | Available | |
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Azacitidine | Film-Coated Tablet | 200mg, 300mg | Available | Q2 2027 | ||
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Baricitinib | Film-Coated Tablet | 1mg, 2mg, 4mg | Q4 2028 | Q3 2030 | ||
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Bortezomib | Powder For Solution For Injection | 3.5mg | Available | Zone IVb | Available | |
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Busulfan | Concentrate For Solution For Infusion | 6mg/ml | Available | Cold Chain | Available | |
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Cabazitaxel | Concentrate For Solution For Infusion | 10mg/ml | Available | Zone IVb | Available | |
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Cabozantinib | Film-Coated Tablet | 20mg, 40mg, 60mg | Available | Zone IVb | Available | |
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Clofarabine | Concentrate For Solution For Infusion | 1mg/ml (20mg/20ml) | Available | Cold Chain | Available | |
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Dabrafenib | Capsule, Hard | 50mg, 75mg | Q4 2026 | Zone IVb | Q3 2028 | |
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Darolutamide | Film-Coated Tablet | 300mg | Q2 2030 | Zone IVb | Q1 2032 | |
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Docetaxel - one vial | Concentrate For Solution For Infusion | 20mg/ml (20mg/ml, 80mg/4ml, 140mg/7ml) | Available | Zone IVb | Available | |
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Docetaxel - two vials | Concentrate & Solvent For Solution for Infusion | 40mg/ml (20mg/0.5ml, 80mg/2ml) | Available | Available | ||
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Doxorubicin | Concentrate For Solution For Infusion | 2mg/ml (10mg/5ml, 20mg/10ml, 50mg/25ml, 100mg/50ml, 200mg/100ml) | Available | Zone IVb | Available | |
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Enzalutamide | Film-Coated Tablet | 40mg, 80mg | Available | Zone IVb | Available | |
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Epirubicin | Solution | 2mg/ml (10mg/5ml, 20mg/10ml, 50mg/25ml, 100mg/50ml, 200mg/100ml) | Available | Zone IVb | Available | |
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Everolimus | Tablet | 2.5mg, 5mg, 10mg | Available | Zone IVb | Available | |
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Filgrastim | Solution For Injection (PFS) | 30MIU/0.5ml, 48MIU/0.8ml | Available | Zone IVb | Available | |
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Fingolimod | Capsule, Hard | 0.25mg, 0.5mg | Available | Zone IVb | Available | |
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Fludarabine | Concentrate For Solution For Infusion | 25mg/ml (50mg/2ml) | Available | Cold Chain | Available | |
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Gefitinib | Film-Coated Tablet | 250mg | Available | Zone IVb | Available | |
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Gemcitabine | Concentrate For Solution For Infusion | 40mg/ml (200mg/5ml, 1000mg/25ml, 2000mg/50ml) | Available | Available | ||
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Irinotecan | Concentrate For Solution For Infusion | 20mg/ml (40mg/2ml, 100mg/5ml, 300mg/15ml, 500mg/25ml) | Available | Zone IVb | Available | |
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Lenalidomide | Capsule, Hard | 2.5mg, 5mg, 7.5mg, 10mg, 15mg, 20mg, 25mg | Available | Zone IVb | Available | |
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Nintedanib | Capsule, Soft Gel | 100mg, 150mg | Available | Available | ||
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Osimertinib | Film-Coated Tablet | 40mg, 80mg | Q2 2029 | Zone IVb | Q1 2031 | |
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Paclitaxel | Concentrate For Solution For Infusion | 6mg/ml (30mg/5ml, 100mg/16.7ml, 150mg/25ml, 260mg/43.33ml, 300mg/50ml) | Available | Zone IVb | Available | |
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Palbociclib | Film-Coated Tablet | 75mg, 100mg, 125mg | Available | Zone IVb | Q4 2026 | |
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Pirfenidone | Film-Coated Tablet | 267mg, 801mg | Available | Zone IVb | Available | |
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Plerixafor | Solution For Injection | 20mg/ml | Available | Available | ||
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Pomalidomide | Capsule, Hard | 1mg, 2mg, 3mg, 4mg | Available | Available | ||
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Ponatinib | Film-Coated Tablet | 15mg, 30mg, 45mg | Available | Q2 2027 | ||
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Ribociclib | Film-Coated Tablet | 200mg | Q1 2029 | Zone IVb | Q4 2030 | |
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Ruxolitinib | Tablet | 5mg, 10mg, 15mg, 20mg, 25mg | Available | Zone IVb | Q1 2027 | |
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Sorafenib | Film-Coated Tablet | 200mg | Available | Zone IVb | Available | |
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Tacrolimus | Capsule, Prolonged Release | 0.5mg, 1mg, 3mg, 5mg | Available | Zone IVb | Available | |
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Tofacitinib | Film-Coated Tablet | 5mg, 10mg | Available | Zone IVb | Q3 2026 | |
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Trametinib | Film-Coated Tablet | 0.5mg, 2mg | Available | Zone IVb | Q3 2027 | |
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Venetoclax | Film-Coated Tablet | 10mg, 50mg, 100mg | Q4 2028 | Zone IVb | Q3 2030 | |
| L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Vinorelbine | Concentrate for Solution for Infusion | 10mg/ml, 50mg/5ml | Available | Zone IVb | Available | |
| M - MUSCULO-SKELETAL SYSTEM | Caffeine/Ibuprofen | Film-Coated Tablet | 100mg/400mg | Available | Available | ||
| M - MUSCULO-SKELETAL SYSTEM | Celecoxib | Capsule, Hard | 100mg, 200mg | Available | Zone IVb | Available | |
| M - MUSCULO-SKELETAL SYSTEM | Colchicine | Tablet | 0.5mg | Available | Available | ||
| M - MUSCULO-SKELETAL SYSTEM | Febuxostat | Film-Coated Tablet | 80mg, 120mg | Available | Zone IVb | Available | |
| M - MUSCULO-SKELETAL SYSTEM | Ibuprofen | Film-Coated Tablet | 200mg, 400mg, 600mg, 800mg | Q1 2027 | Q4 2029 | ||
| M - MUSCULO-SKELETAL SYSTEM | Zoledronic Acid | Concentrate For Solution For Infusion | 4mg/5ml | Available | Zone IVb | Available | |
| N - NERVOUS SYSTEM | Alprazolam | Tablet | 0.25mg, 0.5mg, 1mg, 2mg | Available | Q1 2028 | ||
| N - NERVOUS SYSTEM | Brivaracetam | Film-Coated Tablet | 10mg, 25mg, 50mg, 75mg,100mg | Available | Zone IVb | Available | |
| N - NERVOUS SYSTEM | Bupropion | Prolonged Release Tablet | 150mg | Available | Available | ||
| N - NERVOUS SYSTEM | Fampridine | Prolonged Release Tablet | 10mg | Available | Available | ||
| N - NERVOUS SYSTEM | Fluoxetine | Capsule, Hard | 20mg | Q3 2026 | Q2 2028 | ||
| N - NERVOUS SYSTEM | Gabapentin | Capsule, Hard | 100mg, 300mg, 400mg | Available | Zone IVb | Available | |
| N - NERVOUS SYSTEM | Lacosamide | Film-Coated Tablet | 50mg, 100mg, 150mg, 200mg | Available | Available | ||
| N - NERVOUS SYSTEM | Lamotrigine | Tablet | 25mg, 50mg, 100mg, 200mg | Q4 2026 | Q1 2029 | ||
| N - NERVOUS SYSTEM | Lamotrigine | OroDispersible Tablet | 5mg, 25mg, 50mg, 100mg, 200mg | Q4 2026 | Zone IVb | Q1 2029 | |
| N - NERVOUS SYSTEM | Levetiracetam | Film-Coated Tablet | 250mg, 500mg, 750mg, 1000mg | Available | Available | ||
| N - NERVOUS SYSTEM | Lisdexamfetamine | Capsule, Hard | 20mg, 30mg, 40mg, 50mg, 60mg, 70mg | Available | Zone IVb | Available | |
| N - NERVOUS SYSTEM | Lormetazepam | Tablet | 1mg, 2mg | Q2 2028 | Q1 2030 | ||
| N - NERVOUS SYSTEM | Melatonin | Prolonged Release Tablet | 2mg | Available | Zone IVb | Available | |
| N - NERVOUS SYSTEM | Memantine | Film-Coated Tablet | 5mg, 10mg, 15mg, 20mg | Available | Zone IVb | Available | |
| N - NERVOUS SYSTEM | Mirtazapine | Film-Coated Tablet | 15mg, 30mg, 45mg | Available | Zone IVb | Available | |
| N - NERVOUS SYSTEM | Olanzapine | Film-Coated Tablet | 2.5mg, 5mg, 7.5mg, 10mg, 15mg, 20mg | Available | Zone IVb | Available | |
| N - NERVOUS SYSTEM | Oxazepam | Tablet | 5mg, 10mg, 15mg, 25mg | Q3 2028 | Q2 2030 | ||
| N - NERVOUS SYSTEM | Paracetamol | Tablet | 500mg, 1000mg | Available | Zone IVb | Available | |
| N - NERVOUS SYSTEM | Paracetamol (Fast Acting) | Tablet, Fast Acting | 500mg, 1000mg | Available | Available | ||
| N - NERVOUS SYSTEM | Paracetamol/Codeine | Film-Coated Tablet | 500mg/10mg, 500mg/15mg, 500mg/30mg, 1000mg/60mg | Available | Zone IVb | Available | |
| N - NERVOUS SYSTEM | Paroxetine | Film-Coated Tablet | 10mg, 20mg, 30mg | Available | Available | ||
| N - NERVOUS SYSTEM | Perampanel | Film-Coated Tablet | 2mg, 4mg, 6mg, 8mg, 10mg, 12mg | Available | Available | ||
| N - NERVOUS SYSTEM | Pregabalin | Capsule, Hard | 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg, 300mg | Q1 2027 | Zone IVb | Q2 2028 | |
| N - NERVOUS SYSTEM | Sertraline | Film-Coated Tablet | 25mg, 50mg, 100mg | Q4 2027 | Q3 2029 | ||
| N - NERVOUS SYSTEM | Venlafaxine | Capsule, Modified Release | 37.5mg, 75mg, 150mg | Available | Available | ||
| N - NERVOUS SYSTEM | Vortioxetine | Film-Coated Tablet | 5mg, 10mg, 15mg, 20mg | Available | Q2 2027 | ||
| R - RESPIRATORY SYSTEMS | Azelastine/Fluticasone | Nasal Spray | 137mcg/50mcg | Available | Available | ||
| R - RESPIRATORY SYSTEMS | Budesonide | Nebulizer Suspension | 0.25mg/2ml, 0.5mg/2ml, 1mg/2ml | Available | Zone IVb | Available | |
| R - RESPIRATORY SYSTEMS | Desloratadine | Tablet | 5mg | Available | Zone IVb | Q2 2027 | |
| R - RESPIRATORY SYSTEMS | Desloratadine | Oral Solution | 0.5mg/ml | Available | Zone IVb | ||
| R - RESPIRATORY SYSTEMS | Fluticasone Furoate | Nasal Spray | 27.5µg/actuation | Available | Zone IVb | Available | |
| R - RESPIRATORY SYSTEMS | Ivacaftor | Film-Coated Tablet | 150mg | Available | Q3 2026 | ||
| R - RESPIRATORY SYSTEMS | Levodropropizine (OTC) | Tablet | 60mg | Available | Available | ||
| R - RESPIRATORY SYSTEMS | Levodropropizine (OTC) | Oral Liquid | 6mg/ml | Available | Available | ||
| R - RESPIRATORY SYSTEMS | Mometasone Furoate | Nasal Suspension | 50µg | Available | Zone IVb | Available | |
| R - RESPIRATORY SYSTEMS | Montelukast | Film-Coated Tablet | 10mg | Available | Zone IVb | ||
| R - RESPIRATORY SYSTEMS | Promethazine | Film-Coated Tablet | 25mg | Available | Available |
*Not all products are immediately available for launch. Not all the products are available for all territories. Please check availability with Medis Business Development or send your enquiry to medis@medis.is.